文献速递腹部介入US

微血管血流成像在经动脉化疗栓塞术后残留或复发肝细胞癌中的应用:与彩色/能量多普勒成像的比较

Microvascular Flow Imaging of Residual or Recurrent Hepatocellular Carcinoma after Transarterial Chemoembolization: Comparison with Color/Power Doppler Imaging.
PubMed 文献 · Korean J Radiol · 2019-01-01

这项前瞻性研究纳入100例经动脉化疗栓塞术后疑似残留或复发的肝细胞癌患者(100个病灶,平均2.2 cm),以超声造影或肝动脉造影为参考标准,比较微血管血流成像与彩色/能量多普勒成像检测瘤内血流的能力。微血管血流成像的敏感度和准确率显著高于彩色多普勒和能量多普勒。

要点

  • 以超声造影或肝动脉造影为参考,微血管血流成像检测瘤内血流的敏感度为79.3%(69/87),准确率为80.0%(80/100)。
  • 彩色多普勒敏感度27.6%(24/87)、准确率37.0%(37/100),能量多普勒敏感度36.8%(32/87)、准确率44.0%(44/100)。
  • 微血管血流成像的观察者内ICC>0.9、观察者间ICC>0.6。

核心结论

  • 在经动脉化疗栓塞术后疑似残留或复发的肝细胞癌中,微血管血流成像检测瘤内血流的敏感度和准确率显著高于彩色多普勒和能量多普勒。

研究设计与样本

  • 前瞻性研究,纳入100例经动脉化疗栓塞术后患者共100个肝细胞癌病灶(平均大小2.2 cm),使用RS85超声扫描仪(Samsung Medison Co., Ltd.)依次进行彩色多普勒、能量多普勒和微血管血流成像,以肝动脉造影或超声造影为参考标准。

关键影像表现/征象

  • 微血管血流成像检测瘤内血流的敏感度为79.3%(69/87),准确率为80.0%(80/100)。
  • 彩色多普勒检测瘤内血流的敏感度为27.6%(24/87),准确率为37.0%(37/100)。
  • 能量多普勒检测瘤内血流的敏感度为36.8%(32/87),准确率为44.0%(44/100)。
  • 微血管血流成像的敏感度和准确率均显著高于彩色多普勒和能量多普勒(均p<0.05)。

诊断标准与关键数值

  • 以肝动脉造影或超声造影显示瘤内血流为参考标准,参考标准显示87%(87/100)的肿瘤存在瘤内血流。
  • 两位放射科医师采用5分法共识评估瘤内血流。
  • 微血管血流成像观察者内ICC>0.9,观察者间ICC>0.6;彩色多普勒和能量多普勒的观察者内ICC>0.9、观察者间ICC>0.6。

临床应用与阅片要点

  • 对于经动脉化疗栓塞术后疑似残留或复发的肝细胞癌,微血管血流成像检测瘤内血流的敏感度和准确率显著高于彩色多普勒和能量多普勒。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To determine the feasibility of microvascular flow imaging (MVFI) in comparison with color/power Doppler imaging (CDI/PDI) for detection of intratumoral vascularity in suspected post-transarterial chemoembolization (TACE) residual or recurrent hepatocellular carcinomas (HCCs) by using contrast-enhanced ultrasonography (CEUS) or hepatic angiography (HA) findings as the reference standard.

MATERIALS AND METHODS: One hundred HCCs (mean size, 2.2 cm) in 100 patients treated with TACE were included in this prospective study. CDI, PDI, and MVFI were performed in tandem for evaluating intratumoral vascularity of the lesions by using an RS85 ultrasound scanner (Samsung Medison Co., Ltd.). Intratumoral vascularity in each technique was assessed by two radiologists in consensus by using a 5-point scale. Then, one of the two radiologists and another radiologist performed additional image review in the reverse order (MVFI-PDI-CDI) for evaluation of intra- and interobserver agreements. Results were then compared with those of either HA or CEUS as the reference. The McNemar test, logistic regression analysis, and intraclass correlation coefficient (ICC) were used.

RESULTS: CEUS or HA revealed intratumoral vascularity in 87% (87/100) of the tumors. Sensitivity (79.3%, 69/87) and accuracy (80.0%, 80/100) of MVFI were significantly higher than those of CDI (sensitivity, 27.6% [24/87]; accuracy, 37.0% [37/100]) or PDI (sensitivity, 36.8% [32/87]; accuracy, 44.0% [44/100]) (all p < 0.05). CDI, PDI, and MVFI presented excellent intraobserver (ICCs > 0.9) and good interobserver agreements (ICCs > 0.6).

CONCLUSION: MVFI demonstrated significantly higher sensitivity and accuracy than did CDI and PDI for the detection of intratumoral vascularity in suspected residual or recurrent HCCs after TACE.

来源:Korean J Radiol,查看原文。版权归原作者所有。

引用

  1. Kang HJ, Lee JM, Jeon SK, et al. Microvascular Flow Imaging of Residual or Recurrent Hepatocellular Carcinoma after Transarterial Chemoembolization: Comparison with Color/Power Doppler Imaging. Korean J Radiol. 2019. PMID: 31270975. doi:10.3348/kjr.2018.0932

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。